Literature DB >> 1389004

L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine.

D E Dluzen1, F T Kratko.   

Abstract

In the present experiment we tested the effects of L-DOPA upon dopamine (DA) efflux in vitro from superfused corpus striatal tissue fragments in medium containing reserpine. The purposes of this experiment were first, to evaluate the effects of differing infusion modes of L-DOPA upon DA efflux under conditions in which DA storage capacity has been diminished, and second, to compare this L-DOPA stimulated DA efflux with that of other putative DA secretagogues such as amphetamine and potassium. No differences were obtained in stimulated DA efflux between superfusions performed in the presence or absence of reserpine (10 microM) in the medium when L-DOPA (5 microM) was infused in a continuous (70 minute) mode during the superfusion. In contrast, a continuous infusion of either amphetamine (10 microM) or high potassium (30 mM) resulted in significantly greater stimulated DA efflux in superfusions performed with reserpine in the medium. In addition, when L-DOPA (5 microM) was administered for a brief 10-minute infusion period, a significantly greater stimulated DA efflux was obtained with superfusions containing reserpine in the medium. These results suggest that the mode of L-DOPA infusion may be an important factor in regulating DA release under conditions of diminished DA storage capacity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389004     DOI: 10.1007/bf01250672

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  21 in total

1.  Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-dopa, potassium, and amphetamine.

Authors:  D E Dluzen; J L McDermott; V D Ramirez
Journal:  Exp Neurol       Date:  1991-05       Impact factor: 5.330

2.  Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.

Authors:  K L Leenders; A J Palmer; N Quinn; J C Clark; G Firnau; E S Garnett; C Nahmias; T Jones; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

3.  Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: I. Effects of dopamine precursors, reserpine, amphetamine, and L-DOPA decarboxylase and monoamine oxidase inhibitors.

Authors:  S Ofori; C Bretton; P Hof; M Schorderet
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

4.  Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease.

Authors:  M M Mouradian; I J Heuser; F Baronti; T N Chase
Journal:  Ann Neurol       Date:  1990-01       Impact factor: 10.422

5.  Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists.

Authors:  T M Engber; Z Susel; J L Juncos; T N Chase
Journal:  Eur J Pharmacol       Date:  1989-09-22       Impact factor: 4.432

6.  Continuous oral administration of L-dihydroxyphenylalanine (L-DOPA) solution to patients with advanced Parkinson's disease.

Authors:  J P Bennett; M Turk; E Landow
Journal:  Clin Neuropharmacol       Date:  1989-08       Impact factor: 1.592

7.  Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.

Authors:  D C German; B A McMillen; M K Sanghera; S I Saffer; P A Shore
Journal:  Brain Res Bull       Date:  1981-02       Impact factor: 4.077

8.  Progesterone enhances L-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen-primed rats.

Authors:  D E Dluzen; V D Ramirez
Journal:  Brain Res       Date:  1989-08-07       Impact factor: 3.252

Review 9.  Rationale for continuous dopaminomimetic therapy of Parkinson's disease.

Authors:  T N Chase; F Baronti; G Fabbrini; I J Heuser; J L Juncos; M M Mouradian
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

10.  PC12 cells: a model system for studying drug effects on dopamine synthesis and release.

Authors:  B Kittner; M Bräutigam; H Herken
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-04
View more
  1 in total

1.  The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.

Authors:  D E Dluzen; B Liu
Journal:  J Neural Transm Gen Sect       Date:  1994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.